Insiders AbbVie Inc. Buenos Aires S.E.

Equities

End-of-day quote Buenos Aires S.E. Other stock markets 06:00:00 2024-07-15 pm EDT			5-day change	1st Jan Change
16.9 ^USD	+0.60%		+2.11%	+11.18%

Jul. 12	AbbVie Submits FDA, EMA Applications for Upadacitinib to Treat Giant Cell Arteritis	MT
Jul. 12	AbbVie Seeks U.S., Europe OK of Rinvoq in Giant Cell Arteritis	DJ

Abbvie Announces Appointment of Roopal Thakkar as Executive Vice President, Research & Development and Chief Scientific Officer	Jul. 10	CI
Merus Names New Chief Medical Officer	Jul. 01	MT
AbbVie: new CEO takes up post	Jul. 01	CF
AbbVie Says Robert Michael Assumes CEO Role	Jul. 01	MT
AbbVie Announces Board Changes	Jul. 01	CI
AbbVie Inc. Announces Board of Directors Changes	Jun. 20	CI
Abbvie Inc. Announces Board Changes, Effective July 1, 2024	Apr. 26	CI
Abbvie Insider Sold Shares Worth $3,716,757, According to a Recent SEC Filing	Mar. 22	MT
Abbvie Insider Sold Shares Worth $10,539,508, According to a Recent SEC Filing	Mar. 21	MT
Repeat & Correct : Pfizer to Raise Around $3.5 Billion From Haleon Shares Sale -- Update	Mar. 19	DJ
Pfizer to Raise Around $4.27 Billion From Haleon Shares Sale -- Update	Mar. 19	DJ
Abbvie Insider Sold Shares Worth $1,754,555, According to a Recent SEC Filing	Mar. 01	MT
Abbvie Insider Sold Shares Worth $12,153,957, According to a Recent SEC Filing	Mar. 01	MT
Abbvie Insider Sold Shares Worth $908,688, According to a Recent SEC Filing	Mar. 01	MT
Abbvie Insider Sold Shares Worth $2,509,002, According to a Recent SEC Filing	Mar. 01	MT
Abbvie Insider Sold Shares Worth $9,184,048, According to a Recent SEC Filing	Feb. 23	MT
AbbVie CEO to Retire; COO Robert Michael Named Successor	Feb. 20	MT
AbbVie Names Robert Michael CEO, Richard Gonzalez Executive Chair	Feb. 20	MT
AbbVie Names Robert Michael to Succeed Richard Gonzalez as CEO	Feb. 20	DJ
AbbVie Names President Robert Michael as CEO	Feb. 20	MT

No results for this search